© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
429305 |
As an accredited 3-Bromothieno[3,2-C]Pyridin-4-Amine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 3-Bromothieno[3,2-C]Pyridin-4-Amine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Science builds bridges between simple molecules and life-saving breakthroughs, and every day, chemists choose specialized building blocks to shape discoveries. Among these, 3-Bromothieno[3,2-C]Pyridin-4-Amine stands out with its unique fusion of a thienopyridine core and targeted halogenation. Many in the research community turn to this molecule during early-stage drug design, owing to the chemical versatility that emerges from both its structure and its amine functionality.
Over years of lab experience, I have found few tools as adaptable as heterocyclic compounds. Here, the thienopyridine group creates interesting reactivity, especially when paired with a strategically placed bromine atom at the third position. This design does not come by accident; each functional group directs how the molecule interacts with others. For those working in medicinal chemistry, such substitutions often spell the difference between an inactive compound and one with remarkable biological activity.
3-Bromothieno[3,2-C]Pyridin-4-Amine wears its modifications with pride. The bromine atom changes the electron distribution, which chemists use to target specific enzyme binding pockets or receptor sites. With the amine group at the fourth position, this molecule slips easily into common transformations, including cross-coupling, acylation, reductive amination, and more. These possibilities give research teams the chance to generate small molecule collections rapidly or fabricate advanced intermediates for more elaborate syntheses.
In a practical laboratory, 3-Bromothieno[3,2-C]Pyridin-4-Amine offers real value beyond textbook applications. Medicinal chemists put it to work when chasing novel kinase inhibitors, anti-infective compounds, and fragments for fragment-based drug discovery. The adaptability is not limited to pharmaceuticals; agrochemical research and specialty chemical development also draw from this molecule’s toolkit.
I recall one of my own early projects, focused on synthesizing small sets of kinase inhibitors with unique selectivity. Introducing 3-Bromothieno[3,2-C]Pyridin-4-Amine at a key step enabled a leap in structural diversity without a leap in synthetic complexity. By incorporating this building block, I accessed complex ring systems using mild conditions, then decorated these scaffolds with a wide range of functional groups. In hundreds of experiments, the compound retained its stability, even under strong heating or in the presence of bases—an essential trait for multi-step syntheses.
The pharmaceutical industry often reaches for substituted thieno[3,2-c]pyridines, but bromination at the third position is no generic tweak. Research and patent filings on neighboring analogs show meaningful shifts in both selectivity and potency with small changes. The placement of a bromine atom brings huge improvements in reactivity for palladium-catalyzed couplings, which are one of the main engines for drug exploration.
Most commercial building blocks either offer too few sites for further functionalization, or crowd the molecule with groups that complicate downstream chemistry. Here, the 3-Bromothieno[3,2-C]Pyridin-4-Amine keeps its options open. Alternatives without an amine group at the four position, for example, struggle to engage in nucleophilic reactions or to serve as points of diversification. Others with larger halogens or at different sites can destabilize the ring system or cause off-target effects that muddy up assay data.
Add to that, aromatic amines sometimes introduce toxicity risks, yet extensive assay work indicates that the fused thienopyridine skeleton offers a profile many medicinal chemists prefer. It strikes the right balance between reactivity and manageability — an equation hard-won from a long history of molecular tinkering.
A recurring theme in synthesis is efficiency. Scalability, yield consistency, and the ability to handle many transformation pathways matter just as much as headline-grabbing innovation. Out on the benchtop, I have watched teams invest weeks in molecules that resisted functionalization or purification. In comparison, 3-Bromothieno[3,2-C]Pyridin-4-Amine offers a smoother ride, especially under Suzuki and Buchwald-Hartwig protocols. The bromine position grants firm reactivity, avoiding extra time, extra waste, and extra cost.
For custom syntheses, I rarely welcome solvents packed with protective groups or reaction conditions that require a surgeon’s touch. This compound, due to its innate reactivity and ring stability, reduces the reliance on such hassles. It handles moderate temperatures, tolerates a spectrum of bases, and exits reactions in high yields—traits that save both labor and materials.
Consider the needs of an early-stage medicinal chemistry team: unpredictable timelines, shifting priorities, and often tight budgets. A compound like 3-Bromothieno[3,2-C]Pyridin-4-Amine fits into parallel synthesis workflows, supporting rapid exploration of chemical space. Its compatibility with high-throughput screening workflows makes it a reliable choice when every week counts.
In collaborative research, colleagues often want accessible intermediates for modular assembly. The amine serves as a natural handle for extension, and the bromo group acts as an entry point for arylation, alkylation, or heterocycle construction. Chemical supply companies rarely keep an endless stock of novel intermediates, so finding a molecule that covers key chemistries fosters progress rather than bottlenecks.
No molecule exists in a vacuum, and materials used in discovery phases can influence both lab safety and wider ecological concerns. Substances containing aromatic amines once drew regulatory focus, yet advances in synthetic control and purification now keep exposure within safer limits. Thanks to its moderate size and lack of overly reactive byproducts, 3-Bromothieno[3,2-C]Pyridin-4-Amine generates less hazardous waste compared to multi-step analogues requiring extensive deprotection or halogen exchange steps.
A balance between necessary reactivity and manageable safety risks defines 3-Bromothieno[3,2-C]Pyridin-4-Amine’s profile. Labs with strong chemical management protocols minimize exposure, controlling both airborne and skin contact during reaction setup and isolation. Both high school chemistry students and seasoned postdoctoral researchers build habits around gloves, hoods, and labeling for compounds like this, supporting advancing research without unacceptable risks.
Modern patent literature reveals a surge in chemical matter drawing from the thienopyridine core—rarely do those breakthroughs stick to plain rings, and fewer still ignore the effect of targeted halogenation. 3-Bromothieno[3,2-C]Pyridin-4-Amine makes a mark here by allowing structural modifications unlikely to appear in generic libraries. Chemists working with this building block expand intellectual property portfolios and seed partnerships thanks to the specific novelty offered by such fused heterocycles.
From an in-house perspective, the ability to modify either the ring scaffold or attachments through this intermediate extends the life and reach of discovery programs. Companies targeting unexplored targets in oncology, neurodegeneration, or infectious disease find value in highly decorated scaffolds. At the same time, the ease of carrying bromine through multiple steps allows newer entries at late stages of a synthesis, increasing flexibility while keeping risks under control.
In the race to address diseases beyond the reach of traditional molecules, research teams need every edge. 3-Bromothieno[3,2-C]Pyridin-4-Amine gives seasoned chemists the tools to reach into fresh “chemical space” with less trial and error. The pathway to progress often zigzags through many analogues, failed reactions, and tough-to-handle intermediates. My own notebook brims with reminders that the right building block turns a longshot hypothesis into a confirmable result, especially when time and resources are on the line.
The flexibility of this compound lets teams modify drug-like properties—solubility, stability, and binding efficiency—at stages that would otherwise shut down lines of inquiry. Combined with its good shelf stability, 3-Bromothieno[3,2-C]Pyridin-4-Amine can sit in a well-organized compound file, ready to fuel sprints of activity or low-key exploratory studies. The bottleneck in early-stage R&D rarely sits in winsome headlines, but rather in day-to-day access to scaffolds that don’t limit imagination or workflow.
Reliance on shared scientific evidence defines progress in chemistry. While proprietary interests occasionally keep full datasets under wraps, a growing movement in precompetitive research shares synthetic routes and assay data on molecules like 3-Bromothieno[3,2-C]Pyridin-4-Amine. In my experience, firms that document not only successful conditions, but also notes on solubility, crystal handling, and analytical validation, contribute most to reproducibility—one of the pillars of credible scientific advance.
Quality control takes time, yet the feedback loops generated support both internal decision-making and wider community trust. Using rigorous HPLC, NMR, and MS techniques ensures that any adduct, impurity, or degradation product does not muddy results. 3-Bromothieno[3,2-C]Pyridin-4-Amine stands out as a compound that accommodates comprehensive analytic validation alongside practical use. Its defined melting range and clean NMR spectrum reinforce reliable use in SAR (structure-activity relationship) studies.
Experience, expertise, authoritativeness, and trust all play a role in responsible chemical handling and commentary. Years spent in synthetic labs, collaborating with pharmacologists and materials scientists alike, have taught me the difference between chasing the latest trend and backing claims up with solid precedent. Hands-on use of 3-Bromothieno[3,2-C]Pyridin-4-Amine shows performance gains that align with published literature and conference reports from respected sources.
A culture of ongoing education, not simply stock management, ensures both junior and senior researchers understand the reasons behind each protocol. Drawing connections between molecular structure, chemical reactivity, and ultimate application builds institutional knowledge, which then supports both compliance and innovation. Only through such ground-level diligence does the promise of modern chemical tools come through in safer labs, faster discoveries, and more impactful results.
With the growing interest in complex heterocycles, access remains as much about distribution as about chemical design. Laboratories that rely on 3-Bromothieno[3,2-C]Pyridin-4-Amine benefit from suppliers who invest in cold-chain logistics and rapid restocking protocols. I recall delayed projects that traced back to spotty delivery rather than failed experiments, highlighting the need for robust supply chains.
Laboratory scale often differs from industrial batch runs. Research-grade lots of 3-Bromothieno[3,2-C]Pyridin-4-Amine reach teams in secure, labeled containers, accompanied by certifications and analytic summaries that support best practices in inventory. With broad adoption, market forces lower cost barriers, giving smaller teams and less funded labs a fair shot at impactful science.
Interdisciplinary research projects need building blocks that translate across fields—drug design, materials research, or even high-performance electronics. The same fundamental reactivity profile that makes 3-Bromothieno[3,2-C]Pyridin-4-Amine valuable in medicinal chemistry opens doors in other fields, including the search for organic semiconductors or catalytically active motifs.
Personal interactions with materials scientists in my institution revealed surprising cross-over applications, where the compound’s rigid core and functional handles suited prototype devices as much as exploratory ligands. Without structural complexity beyond what common analytical tools can confirm, teams bridge expertise gaps and foster new lines of inquiry.
All chemical manufacturing brings waste management and process efficiency into sharp focus. Compared with more functionalized relatives, 3-Bromothieno[3,2-C]Pyridin-4-Amine enables shorter synthetic routes, minimizing step count and solvent use. Scaling up reactions with this intermediate, teams observe reductions in purification cycles. The practical upshot is less solvent disposal and lower reagent consumption.
Cost savings do not emerge solely from price per gram but from unbottlenecked workflows, efficient use of time, and fewer failed reactions. Projects that swap out more ornamental intermediates for this building block often close screening rounds faster, redirecting grants or revenue to subsequent phases. The margin for error never disappears, yet every shortcut to actionable results strengthens both the case for continued funding and the morale of research teams.
Tomorrow’s scientific problems demand both foundational tools and flexible thinking. As AI-driven molecular design expands the number of viable chemical structures, the need for robust, well-characterized intermediates like 3-Bromothieno[3,2-C]Pyridin-4-Amine only grows. Its role in template-driven synthesis, bioisostere development, and probe generation positions it as a quiet engine behind countless programs.
Connections made through conferences, preprint servers, and online communities continue to steer new researchers toward compounds with proven track records. As more data accumulates and as analytical sharing becomes standard, expectations rise. The best building blocks, including 3-Bromothieno[3,2-C]Pyridin-4-Amine, fuel breakthroughs not merely by showing up on an order sheet but by shaping an era of rapid, rigorous, and trustworthy experimentation.
